Dr Ruth Appleby presents at NZ BIO Conference.
National Business Review 13th October 2017
See report on Upstream Medical Technologies presentation at the NZBIO Conference in Wellington, New Zealand on 13th October 2017.
Detecting at-risk heart attack patients, a step closer with $2m investment
Upstream Medical Technologies, a leading deep-tech company focused on developing innovative solutions for heart disease, announced today that it has closed a significant capital round to further advance its frontline diagnostic tests for cardiac diseases.
Upstream commences testing Marker C on the APACE cohort
The next phase of development is now underway, with the commencement of testing Marker C on the APACE cohort.